Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
1.650
+0.070 (4.43%)
At close: Jul 14, 2026, 4:00 PM EDT
1.601
-0.049 (-2.98%)
After-hours: Jul 14, 2026, 6:46 PM EDT
Acurx Pharmaceuticals Market Cap
Acurx Pharmaceuticals has a market cap or net worth of $7.09 million as of July 14, 2026. Its market cap has decreased by -29.77% in one year.
Market Cap
7.09M
Enterprise Value
-2.16M
1-Year Change
-29.77%
Ranking
Category
Stock Price
$1.65
Market Cap Chart
Since the IPO on June 25, 2021, Acurx Pharmaceuticals's market cap has decreased from $57.25M to $7.09M, a decrease of -87.61%. That is a compound annual growth rate of -33.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 7.09M | 21.28% |
| Dec 31, 2025 | 5.85M | -57.48% |
| Dec 31, 2024 | 13.75M | -73.92% |
| Dec 29, 2023 | 52.73M | 14.29% |
| Dec 30, 2022 | 46.14M | 4.51% |
| Dec 31, 2021 | 44.15M | -22.88% |
| Jun 25, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jupiter Neurosciences | 7.60M |
| AEON Biopharma | 7.44M |
| Kairos Pharma | 7.30M |
| PharmaCyte Biotech | 7.30M |
| CNS Pharmaceuticals | 7.15M |
| Can-Fite BioPharma | 7.07M |
| Ernexa Therapeutics | 7.02M |
| Cadrenal Therapeutics | 6.70M |